Molecular and Cellular Biology, June 2001, p. 3959-3963, Vol. 21, No. 12
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.12.3959-3963.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Medicine, Division of Metabolism, Endocrinology and Nutrition1 and Department of Pharmacology,3 University of Washington, Seattle, Washington 98195, and Veterans Affairs Puget Sound Health Care System, Seattle, Washington 981082
Received 15 March 2001/Accepted 28 March 2001
| |
ABSTRACT |
|---|
|
|
|---|
The protein kinase inhibitor (PKI) family includes three genes
encoding small, heat-stable inhibitors of the cyclic AMP-dependent kinase PKA. Each PKI isoform contains a PKA inhibitory domain and a
nuclear export domain, enabling PKI to both inhibit PKA and remove it
from the nucleus. The PKI
isoform, also known as testis PKI, is
highly expressed in germ cells of the testis and is found at more
modest levels in other tissues. In order to investigate its
physiological role, we have generated PKI
knockout mice by gene
targeting. These mice exhibit a partial loss of PKI activity in testis
but remain fertile with normal testis development and function. PKI
knockout females also reproduce normally. The PKI
mutants were
crossed with our previously derived PKI
mutants to obtain
double-knockout mice. Remarkably, these mice are also viable and
fertile with no obvious physiological defects in either males or females.
| |
INTRODUCTION |
|---|
|
|
|---|
Many hormones and neurotransmitters initiate their physiological actions by stimulating production of the intracellular second messenger, cyclic AMP (cAMP). The downstream target of cAMP is the cAMP-dependent kinase PKA. Many other proteins and enzymes modulate this pathway, including PKI, a highly specific inhibitor of PKA.
PKI is a small, heat-stable protein with high affinity for the catalytic subunit of PKA, and binding of PKI to the catalytic subunit inhibits its activity (15, 23). PKI also contains a leucine-rich region that has been shown to function as a nuclear export signal when PKI is bound to PKA (8, 24). PKI is capable of freely entering the nucleus and actively shuttling the catalytic subunit of PKA back to the cytoplasm, where PKA regulatory subunits are located. By facilitating nuclear export of PKA, PKI is thought to affect the kinetics and/or extent of PKA activity in the nucleus. PKI may, for example, terminate the transcriptional regulation by PKA of specific genes and rapidly reset the PKA system for subsequent gene induction responses.
There are three distinct PKI genes encoding homologous isoforms,
referred to as PKI
, PKI
, and PKI
(7, 12, 14, 19, 20). Each of these isoforms has a unique tissue expression
pattern (2, 7, 16, 19). The PKI
isoform is highly
expressed in skeletal muscle, heart, cerebral cortex, and cerebellum,
whereas the PKI
isoform (originally called testis PKI) is most
highly expressed in testis, with a small amount of expression in brain and little to none elsewhere. PKI
mRNA is widely expressed and found
most highly expressed in heart and testis. Some tissues possess
multiple isoforms of PKI, in which case the expression pattern is cell
specific. In the testis, for example, PKI
is localized to the
Sertoli cells and PKI
is localized to the germ cells
(18).
We previously reported on the gene targeting of the PKI
gene in mice
(9). Despite the presence of PKI
in Sertoli cells of
the wild-type testis, PKI
knockout mice showed no defect in testis
development, spermatogenesis, or fertility, demonstrating the
expendability of PKI
for Sertoli cell function. In contrast, defects
in skeletal muscle, where PKI
is most highly expressed in the wild
type, were observed. Knockout skeletal muscle showed a complete absence
of PKI activity, suggesting a lack of any compensation by other PKI
isoforms. Surprisingly, the mice exhibited a counterintuitive decrease
in basal PKA activity and a reduction in both basal and isoproterenol-induced gene expression, apparently as a consequence of
diminished phosphorylation of the transcription factor CREB. These
results challenged the prevailing view that PKI is required simply to
maintain low basal PKA activity and terminate the nuclear actions of PKA.
The important role of the cAMP-PKA pathway in testis development and
function has a long history of investigation. Follicle-stimulating hormone, a gonadotropin that signals through cAMP, is essential for
normal development of the testis and production of normal numbers of
sperm. The motility of mature sperm is stimulated by cAMP and
phosphodiesterase inhibitors (10, 17), and this
stimulation is likely to be mediated by PKA (21).
Similarly, capacitation and the acrosome reaction involve PKA
(11, 22). Based on these and other studies, it was
believed that PKA played a pivotal role in testis function. It was
unexpected, therefore, when gene knockouts of the testicular PKA
subunit isoforms RII
(6) and RII
(4) produced mice with normal fertility, sperm development, and function. Of the five viable knockout mouse lines with mutations in individual PKA subunit isoforms (4-6, 13), only the C
catalytic
subunit knockout displayed testicular dysfunction (B. S. Skålhegg, Y. Huang, T. Su, R. L. Idzerda, G. S. McKnight, and K. A. Burton, submitted for publication).
The C
knockout mice had sperm that were nearly devoid of PKA
activity and lacked forward motility. Analysis of the other four
various PKA knockout mouse lines suggested that compensation by other
PKA isoforms allowed for normal cAMP signaling, thus preventing
manifestations of testicular defects.
The high level of PKI
in germ cells of the testis suggests that it
may play an important role in cAMP signaling in these cells. To
elucidate the physiological function of PKI
, we have created
PKI
-deficient mice by homologous recombination in embryonic stem
(ES) cells. By interbreeding with our previously derived PKI
knockout mice (9), we have also produced PKI
/
double-knockout mice. We report here on the phenotypes of these mouse mutants.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Construction of the PKI
targeting vector and generation of
mutant mice.
A PKI
genomic clone was isolated from a 129SV/J
mouse genomic library and given to us by M. Uhler (University of
Michigan). The 4.7-kb EcoRI-AflII fragment,
spanning exon 3, was flanked with thymidine kinase cassettes to
facilitate negative selection. The 0.5-kb
BamHI-SpeI fragment encompassing exon 3 was
replaced with a 1.9-kb neomycin phosphotransferase cassette to
facilitate positive selection. This strategy deleted the inhibitory and
nuclear export domains of PKI
.
heterozygous offspring were obtained. Heterozygotes were interbred to produce homozygous null
mice. Mice were genotyped by genomic Southern blot analysis of DNA
isolated from tail biopsies. All experiments comparing wild-type and
mutant mice used age- and sex-matched animals on the C57BL/6 × 129Ola hybrid background. Animal care and experimentation complied with
all guidelines set forth by the National Institutes of Health, the
University of Washington, and the Veterans Affairs Puget Sound Health
Care System.
Northern blot analysis.
Total RNA was isolated from testis,
and Northern blots were run with 10 µg of RNA per lane as described
previously (4). Blots were stained with methylene blue to
visualize the 28S and 18S RNAs and also probed with the housekeeping
gene encoding cyclophilin to confirm that all lanes had equivalent
amounts of intact RNA. Riboprobes were made from cDNA clones of PKI
and PKI
(gifts from M. Uhler), protamine 1 (gift from R. Braun), and
testis ACE, RT7, and TP1 (Incyte Genomics) using standard techniques.
Sperm counts and motility. The sperm counts and motility of cauda epididymal sperm from male mice, 12 to 15 weeks of age, were assessed in a medium containing 135 mM NaCl, 5 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 10 mM lactic acid, 1 mM sodium pyruvate, 30 mM HEPES, pH 7.4, and 20 mg of bovine serum albumin (fraction V; Sigma)/ml. A Neubauer chamber was used to determine sperm number and motility.
PKI activity assays. Whole testis homogenates were prepared, and PKI activity was assayed essentially as described previously (9). The homogenates were heated for 10 min at 95°C to inactivate endogenous kinases and centrifuged for 10 min at 12,000 × g at 4°C. Equal amounts of heat-inactivated supernatant proteins from three individual mice were pooled, and then 47 µg was added to a kinase assay mixture containing 1 nM purified bovine heart C subunit (Sigma) in 50 µl. Each sample was assayed in triplicate, and the results are reported as percent inhibition of C subunit activity.
| |
RESULTS |
|---|
|
|
|---|
Generation of mice lacking a functional PKI
gene.
A gene
targeting approach was used to inactivate the PKI
gene in embryonic
stem cells. Figure 1A depicts the
targeting vector, along with the resulting mutant PKI
locus. Exon 3 of PKI
, which encodes both the inhibitory and nuclear export
domains, was deleted and replaced by the neomycin resistance cassette.
The mutant ES cells were used to generate heterozygous mutant mice,
which were then bred to produce knockout mice. Genotyping of the
litters from heterozygous crosses (shown in Fig. 1B) demonstrated the presence of wild-type, knockout, and heterozygous offspring at the
expected Mendelian ratio, indicating no embryonic lethality associated
with the mutation. Northern blot analysis confirmed the loss of a
functional PKI
gene; Fig. 1C demonstrates the absence of the PKI
transcript in homozygous testis, the tissue with the highest amount of
PKI
mRNA in wild-type mice. Knockout mice appeared morphologically
normal, with no obvious detrimental effects on health or life span. A
12-week body weight study revealed normal weight gain for the PKI
knockout mice (data not shown).
|
PKI activity in PKI
knockout and PKI
/
double-knockout
mice.
The PKI
knockout mice were interbred with PKI
knockout
mice that we reported on previously (9) to generate double
knockouts. These mice exhibited no noticeable ill effects of having
inactivating mutations in both genes and exhibited normal weight gain
(data not shown). PKI activity was assayed in both lines of mice.
Homogenates were made from testis, where PKI
is expressed at high
levels in germ cells and PKI
is found in Sertoli cells
(18). Homogenates were heated to inactivate endogenous
kinases and then tested for PKA inhibitory activity. As shown in Fig.
2, wild-type mouse homogenates inhibited
nearly 70% of the PKA in the assay, while the PKI
and PKI
/
double-knockout mouse homogenates each inhibited about 47% of the PKA.
Thus, inactivation of the PKI
gene led to a significant loss of PKI
activity in testis, confirming the functional loss of the PKI
gene.
However, the additional loss of PKI
did not lead to a detectable
further decrement in PKI activity, probably due to the small amount of
PKI
present in the wild-type testis. This result is consistent with
our previous studies of PKI
knockout mice, which demonstrated no
change in PKI activity in testis (data not shown). The substantial
amount of residual inhibitory activity in the PKI
and
/
double-mutant testes is presumably contributed by the only other known
isoform of PKI, PKI
. Northern blot analysis revealed no compensatory
change in PKI
mRNA levels in the knockout mice (data not shown),
suggesting that either the normal endogenous level of PKI
is
sufficient for functional compensation or that compensatory increases
in PKI
occur at the protein level.
|
Reproductive function.
The presence of PKI isoforms in
distinct cell types within the testis suggests an important role in
sperm development and/or function. Several parameters of testicular
function were examined in PKI
knockout and PKI
/
double-knockout mice. As displayed in Table
1, testis weights were indistinguishable
among wild-type mice and the two mutant mouse lines. To assess litter
size, males and females of the same genotype were interbred, and the
resulting litters showed no significant differences in size from
wild-type, PKI
knockout, or PKI
/
double-knockout breeders. In
addition, histological analysis of testes from PKI
single and
PKI
/
double knockouts uncovered no abnormalities (data not
shown). Thus, apparently normal reproductive function can occur in both
male and female mice in the absence of both PKI
and PKI
. We
previously reported similar findings for PKI
single-knockout mice
(9). Further sperm analysis was performed on the PKI
knockout mice, revealing no change in sperm number or percent motility
compared with wild-type mice (Table 1).
|
Testicular gene expression.
Because PKI has a nuclear export
signal that serves to chaperone the active catalytic subunit of PKA out
of the nucleus, it is believed that PKI might function to terminate PKA
phosphorylation of nuclear transcription factors, thereby shutting down
transcriptional regulation of specific genes by PKA. Our previous
studies of PKI
knockout mice revealed an unexpected decrease in
expression of genes normally induced by PKA in skeletal muscle
(9), the tissue with the highest PKI
level in wild-type
mice. These results made it difficult to predict the outcome in PKI
mutant mice. Figure 3 depicts gene
expression analysis in PKI
knockout testis. Four germ cell genes
that are known to be regulated by PKA (or potentially regulated by
virtue of cAMP response elements) were examined by Northern blot
analysis in four PKI
knockout and four wild-type mice. No consistent
differences between genotypes were evident for any of the genes,
protamine 1, encoding the testis isoform of angiotensin-converting
enzyme, RT7, or transition protein 1. Together, these data demonstrate
that PKI
is not essential for spermatogenesis and fertility, and its
loss in germ cells of the testis has no detectable effect on gene
expression in those cells.
|
| |
DISCUSSION |
|---|
|
|
|---|
Decades of research support the idea that the cAMP-PKA pathway is
essential for normal testis development and function. The lack of
reproductive phenotypes in most of the PKA isoform knockout mice has
been attributed to compensation by other PKA isoforms (1, 4-6,
13). It appears that a similar phenomenon occurs within the PKI
system. Despite substantial amounts of PKI
in testis, our results
demonstrate that it is clearly dispensable for reproductive function.
The PKI
knockout mice exhibit normal fertility and normal sperm
production and motility (Table 1). Furthermore, expression of putative
PKA-regulated germ cell genes is normal (Fig. 3), suggesting that there
is no perturbation of PKA activity and its regulation.
The PKI
knockouts and PKI
/
double knockouts both show a
significant loss of PKI activity in testis compared with wild-type mice
(Fig. 2). The remaining PKI activity is almost certainly contributed by
PKI
, although it is formally possible that another undiscovered PKI
is expressed in testis. In wild-type mice, PKI
and PKI
mRNA
levels in testis are approximately equal (7). If PKI
activity levels roughly correspond to mRNA levels, then PKI
and
PKI
each contribute about half of the PKI activity normally found in
testis. Therefore, in the PKI
knockout, one might have predicted a
50% loss of PKI activity, but only a 30% reduction was observed. It
is possible that testis PKI
protein levels had increased to
compensate for the loss of PKI
. We ascertained that there was no
change in testis PKI
mRNA, so any compensation would be at the
protein level. Unfortunately, antibodies are not available to directly
assess PKI
protein levels by Western blot. Whether or not PKI
levels increased in response to PKI
loss, PKI
clearly is able to
functionally compensate, consistent with a built-in redundancy in the
PKI system. PKI
is known to be expressed within the germ cell
compartment of the testis, while the cellular localization of PKI
has not been reported. However, the functional compensation of PKI
for PKI
suggests germ cell expression.
The small amount of PKI
present in Sertoli cells does not contribute
significantly to the overall PKI activity in testis, since PKI
knockout mice show no decrement in testis PKI activity (data not
shown). Furthermore, we found no difference in testis PKI activity in
PKI
knockout mice compared with PKI
/
double-knockout mice
(Fig. 2). That the PKI
knockout mice display no reproductive deficiency indicates that PKI
is not needed for normal
follicle-stimulating hormone signaling in Sertoli cells. Whether PKI
is expressed in Sertoli cells is unknown. It is possible that PKI
is
expressed throughout the testis and is able to compensate for the
missing PKI
as well as PKI
. A mouse knockout of PKI
is needed
in order to clarify the role of PKI in reproduction and in other
physiological processes as well.
| |
ACKNOWLEDGMENTS |
|---|
Grants from the National Institutes of Health to R.L.I. (HD 33057) and E.A.G. (training grant T32 DK07247) are gratefully acknowledged.
We thank R. Scott Frayo, Michael W. Schnarr, and Taimane L. Sa'Au for
valuable technical assistance and Susan Carey and Kathy Kafer for
providing essential mouse care and embryo manipulation. We are very
grateful to Michael D. Uhler for providing the PKI
genomic clone.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Washington, Department of Medicine, Box 357138, Seattle, WA 98195. Phone: (206) 616-0481. Fax: (206) 616-0499. E-mail: idzerda{at}u.washington.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Amieux, P. S.,
D. E. Cummings,
K. Motamed,
E. P. Brandon,
L. A. Wailes,
K. Le,
R. L. Idzerda, and G. S. McKnight.
1997.
Compensatory regulation of RIalpha protein levels in protein kinase A mutant mice.
J. Biol. Chem.
272:3993-3998 |
| 2. |
Beale, E. G.,
J. R. Dedman, and A. R. Means.
1977.
Isolation and characterization of a protein from rat testis which inhibits cyclic AMP-dependent protein kinase and phosdiesterase.
J. Biol. Chem.
252:6322-6327 |
| 3. | Brandon, E. P., K. A. Gerhold, M. Qi, G. S. McKnight, and R. L. Idzerda. 1995. Derivation of novel embryonic stem cell lines and targeting of cyclic AMP-dependent protein kinase genes. Recent Prog. Horm. Res. 50:403-408. |
| 4. |
Brandon, E. P.,
S. F. Logue,
M. R. Adams,
M. Qi,
S. P. Sullivan,
A. M. Matsumoto,
D. M. Dorsa,
J. M. Wehner,
G. S. McKnight, and R. L. Idzerda.
1998.
Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice.
J. Neurosci.
18:3639-3649 |
| 5. |
Brandon, E. P.,
M. Zhuo,
Y. Y. Huang,
M. Qi,
K. A. Gerhold,
K. A. Burton,
E. R. Kandel,
G. S. McKnight, and R. L. Idzerda.
1995.
Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RI beta subunit of cAMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
92:8851-8855 |
| 6. |
Burton, K. A.,
B. Treash-Osio,
C. H. Muller,
E. L. Dunphy, and G. S. McKnight.
1999.
Deletion of type IIalpha regulatory subunit delocalizes protein kinase A in mouse sperm without affecting motility or fertilization.
J. Biol. Chem.
274:24131-24136 |
| 7. |
Collins, S. P., and M. D. Uhler.
1997.
Characterization of PKIgamma, a novel isoform of the protein kinase inhibitor of cAMP-dependent protein kinase.
J. Biol. Chem.
272:18169-18178 |
| 8. |
Fantozzi, D. A.,
A. T. Harootunian,
W. Wen,
S. S. Taylor,
J. R. Feramisco,
R. Y. Tsien, and J. L. Meinkoth.
1994.
Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus.
J. Biol. Chem.
269:2676-2686 |
| 9. |
Gangolli, E. A.,
M. Belyamani,
S. Muchinsky,
A. Narula,
K. A. Burton,
G. S. McKnight,
M. D. Uhler, and R. L. Idzerda.
2000.
Deficient gene expression in protein kinase inhibitor null mutant mice.
Mol. Cell. Biol.
20:3442-3448 |
| 10. | Garbers, D. L., and G. S. Kopf. 1980. The regulation of spermatozoa by calcium cyclic nucleotides. Adv. Cyclic Nucleotide Res. 13:251-306[Medline]. |
| 11. | Guraya, S. S. 2000. Cellular and molecular biology of capacitation and acrosome reaction in spermatozoa. Int. Rev. Cytol. 199:1-64[CrossRef][Medline]. |
| 12. |
Olsen, S. R., and M. D. Uhler.
1991.
Isolation and characterization of cDNA clones for an inhibitor protein of cAMP-dependent protein kinase.
J. Biol. Chem.
266:11158-11162 |
| 13. |
Qi, M.,
M. Zhuo,
B. S. Skalhegg,
E. P. Brandon,
E. R. Kandel,
G. S. McKnight, and R. L. Idzerda.
1996.
Impaired hippocampal plasticity in mice lacking the Cbeta1 catalytic subunit of cAMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
93:1571-1576 |
| 14. |
Scarpetta, M. A., and M. D. Uhler.
1993.
Evidence for two additional isoforms of the endogenous protein kinase inhibitor of cAMP-dependent protein kinase in mouse.
J. Biol. Chem.
268:10927-10931 |
| 15. |
Scott, J. D.,
E. H. Fischer,
K. Takio,
J. G. Demaille, and E. G. Krebs.
1985.
Amino acid sequence of the heat-stable inhibitor of the cAMP-dependent protein kinase from rabbit skeletal muscle.
Proc. Natl. Acad. Sci. USA
82:5732-5736 |
| 16. |
Seasholtz, A. F.,
D. M. Gamm,
R. P. Ballestero,
M. A. Scarpetta, and M. D. Uhler.
1995.
Differential expression of mRNAs for protein kinase inhibitor isoforms in mouse brain.
Proc. Natl. Acad. Sci. USA
92:1734-1738 |
| 17. | Tash, J. S., and A. R. Means. 1983. Cyclic adenosine 3',5' monophosphate, calcium and protein phosphorylation in flagellar motility. Biol. Reprod. 28:75-104[Abstract]. |
| 18. |
Van Patten, S. M.,
L. F. Donaldson,
M. P. McGuinness,
P. Kumar,
A. Alizadeh,
M. D. Griswold, and D. A. Walsh.
1997.
Specific testicular cellular localization and hormonal regulation of the PKIalpha and PKIbeta isoforms of the inhibitor protein of the cAMP-dependent protein kinase.
J. Biol. Chem.
272:20021-20029 |
| 19. | Van Patten, S. M., P. Howard, D. A. Walsh, and R. A. Maurer. 1992. The alpha- and beta-isoforms of the inhibitor protein of the 3',5'- cyclic adenosine monophosphate-dependent protein kinase: characteristics and tissue- and developmental-specific expression. Mol. Endocrinol. 6:2114-2122[Abstract]. |
| 20. |
Van Patten, S. M.,
D. C. Ng,
J. P. Th'ng,
K. L. Angelos,
A. J. Smith, and D. A. Walsh.
1991.
Molecular cloning of a rat testis form of the inhibitor protein of cAMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
88:5383-5387 |
| 21. |
Vijayaraghavan, S.,
S. A. Goueli,
M. P. Davey, and D. W. Carr.
1997.
Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility.
J. Biol. Chem.
272:4747-4752 |
| 22. | Visconti, P. E., L. R. Johnson, M. Oyaski, M. Fornes, S. B. Moss, G. L. Gerton, and G. S. Kopf. 1997. Regulation, localization, and anchoring of protein kinase A subunits during mouse sperm capacitation. Dev. Biol. 192:351-363[CrossRef][Medline]. |
| 23. |
Walsh, D. A.,
C. D. Ashby,
C. Gonzalez,
D. Calkins,
E. H. Fischer, and E. G. Krebs.
1971.
Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases.
J. Biol. Chem.
246:1977-1985 |
| 24. | Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|